The House Energy and Commerce Committee has expanded its investigation into safety and compliance issues at the National Institutes of Health Clinical Center in Bethesda, Md., according to a report.
The probe of the NIH research hospital originated almost two years ago, and the House committee recently issued a letter to Director Francis Collins requesting additional documents as the agency has yet to move on actions promised in a report over a year ago, according to Roll Call.
"After about a year since the NIH announced reforms to the NIH Clinical Center, it's imperative the committee have an understanding of additional action taken to address our concerns, and ensure that NIH's efforts to ensure safety and compliance of their work are effective," committee Chairman Greg Walden, R-Ore., and Rep. Tim Murphy, R-Pa., chairman of the panel's oversight subcommittee, wrote in the letter obtained by Roll Call.
The NIH Clinical Center has been under fire of late as House Republicans have issued a letter to President Donald Trump to fire Director Collins for his position on stem-cell research and human cloning. Also, the White House's budget proposal Tuesday cuts funding to the NIH by more than $7 billion for 2018, according to the report.
The NIH has been subjected to congressional and Food and Drug Administration probes amid allegations of using a contaminated drug sample on humans in research. An audit group made up of NIH leaders and non-government executives released an April 2016 report that questioned safety practices and proposed recommendations — some of which have yet to be implemented under Director Collins.
"NIH learned of significant problems with timely reporting of adverse events, which required more immediate action and attention," NIH told Roll Call. "Only after all NIH researchers have a consistent understanding of the expectations for reporting will the forthcoming internal audits turn out meaningful results."
© 2021 Newsmax. All rights reserved.